Levelt E. . .Diabetic Cardiomyopathy: Pathophysiology and Potential Metabolic Interventions State of the Art Review. European Journal of Endocrinology, 178(2018) : R127-R139.
Nagayama K.,Signaling JNK .2015 .Pathways. PLOS ONE, 0137960(9) : .
Ma X.,Potential Therapeutic . .GLP-1 Receptor Agonists (GLP-1RAs): Cardiovascular Actions. International Journal of Biological Sciences, 17(2021) : 2050-2068.
Xie Z.,AMPK-Dependent NF .2021 .Exendin-4 Preserves Blood-Brain Barrier Integrity via GLP-1R/. Inhibition after Subarachnoid Hemorrhage.” Frontiers in Molecular Neuroscience, 750726 : .
Jensen E.P. .2014 .Activation of GLP-1 Receptors on Vascular Smooth Muscle Cells Reduces the Autoregulatory Response in Afferent Arterioles and Increases Renal Blood Flow. American Journal of Physiology-Renal Physiology, 308(2015) : F867-F877.
Liu Z. .2018 .Exendin-4 Promotes the Vascular Smooth Muscle Cell Re-Differentiation through AMPK/SIRT1/FOXO3a Signaling Pathways. ” Atherosclerosis, 07 : 58-66.
Arakawa M. . .Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-Like Peptide-1 Receptor Agonist. , 59(2010) : 1694-1037.
Li A.Q.,Epac1-Dependent Rac1 A.Q. .2014 .Exendin-4 Promotes Endothelial Barrier Enhancement via PKA-. American Journal of Physiology-Cell Physiology, 308(2015) : C164-C175.
Lee J.,Glucagon-Like Peptide Receptor Agonist Inhibits Angiotensin II-Induced Proliferation .2022 .Migration in Vascular Smooth Muscle Cells and Ameliorates PhosphateInduced Vascular Smooth Muscle Cells Calcification. Diabetes & Metabolism Journal, 0363(2024) : 83-96.
Wang Y. . .Exendin-4 Decreases Liver Inflammation and Atherosclerosis Development Simultaneously by Reducing Macrophage Infiltration. British Journal of Pharmacology, 171(2014) : 723-734.
Yan C. .2023 .Exendin-4 Attenuates Atherosclerosis Progression via Controlling Hematopoietic Stem/Progenitor Cell Proliferation. ” Journal of Molecular Cell Biology, 15(3) : .
Du J. .2015 .Exendin-4 Induces Myocardial Protection through MKK3 and Akt-1 in Infarcted Hearts. American Journal of Physiology-Cell Physiology, 310(2016) : C270-C283.
Zhou H. .2015 .Exendin-4 Enhances the Migration of Adipose-Derived Stem Cells to Neonatal Rat Ventricular Cardiomyocyte-Derived Conditioned Medium via the Phosphoinositide 3-Kinase/Akt-Stromal Cell-Derived Factor1α/CXC Chemokine Receptor 4 Pathway. Molecular Medicine Reports, 3243(2015) : 4063-4072.
Ma X.,Potential Therapeutic . .GLP-1 Receptor Agonists (GLP-1RAs): Cardiovascular Actions. International Journal of Biological Sciences, 17(2021) : 2050-2068.
Sun Z. . .PEGylated Exendin-4, a Modified GLP-1 Analog Exhibits More Potent Cardioprotection than Its Unmodified Parent Molecule on a Dose to Dose Basis in a Murine Model of Myocardial Infarction. ” Theranostics, 5(2015) : 240-250.
Yu W.,Attenuate Glucose Toxicity-Induced Cardiac Liraglutide .2018 .Exendin-4. Oxidative Medicine and Cellular Longevity, : .
Zhou H. .2015 .Exendin-4 Enhances the Migration of Adipose-Derived Stem Cells to Neonatal Rat Ventricular Cardiomyocyte-Derived Conditioned Medium via the PI3K/Akt-SDF-1α/CXCR4 Pathway. Molecular Medicine Reports, 3243(2015) : 4063-4072.
Marso S.P. . .. Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.” New England Journal of Medicine, 375(2016) : 311-322.
Punjabi M. .2022 .Liraglutide Lowers Endothelial Vascular Cell Adhesion Molecule-1 in Murine Atherosclerosis Independent of Glucose Levels.” JACC: Basic to Translational Science. , 08(2023) : 256-269.
McLean B.A. . .Revisiting the Complexity of GLP-1 Action from Sites of Synthesis to Receptor Activation.” Endocrine Reviews. , 42(2020) : 101-132.